PRESS RELEASE published on 01/26/2026 at 16:55, 9 months 13 days ago # UnionPay at Davos 2026: Showcasing China's Economic Resilience for a New Global Development Blueprint UnionPay showcased China's economic resilience at Davos 2026, emphasizing innovation, AI technology, global cooperation, and growth potential AI Technology China Economic Resilience UnionPay Davos 2026
PRESS RELEASE published on 01/26/2026 at 16:49, 9 months 13 days ago EQS-Adhoc: GEA Group Aktiengesellschaft: GEA Group AG releases preliminary financials 2025 GEA Group AG releases preliminary financials for 2025, with EBITDA margin of 16.5% exceeding guidance. Q4 order intake surpasses market expectations by 7% EBITDA Margin Order Intake GEA Group 2025 Preliminary Financials
PRESS RELEASE published on 01/26/2026 at 16:07, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. disclosed a 7.66% ownership position in American Axle & Manufacturing Holdings, Inc. on 23 January 2026 Disclosure Vanguard Group Financial Securities Ownership Position American Axle
PRESS RELEASE published on 01/26/2026 at 16:06, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.08% interest in JTC plc. Position disclosed on 23 January 2026 includes 8,758,406 shares of 1p ordinary class The Vanguard Group, Inc. 1p Ordinary JTC Plc 5.08% Interest 8,758,406 Shares
PRESS RELEASE published on 01/26/2026 at 16:06, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses a 4.89% interest in Glencore plc as of 23 Jan 2026. Additional disclosures include dealings in securities Securities Disclosure The Vanguard Group Dealings Glencore Plc
PRESS RELEASE published on 01/26/2026 at 16:05, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 6.02% interest in Avadel Pharmaceuticals plc's securities as of 23 Jan 2026. Purchase and sale transactions detailed in Form 8.3 Securities Vanguard Group Purchase And Sale Transactions Interest Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 01/26/2026 at 16:04, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% interest in Beazley plc. Purchase and sale of 5p ordinary shares detailed in Form 8.3 Form 8.3 Vanguard Group Beazley Plc 5.02% Interest Purchase Sale
PRESS RELEASE published on 01/26/2026 at 16:03, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.59% position in Spire Healthcare Group plc. Details include owning 14,446,914 relevant securities and recent purchase of 1p ordinary shares Position Disclosure Financial Dealings Vanguard Group Spire Healthcare 1p Ordinary Shares
PRESS RELEASE published on 01/26/2026 at 16:02, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc The Vanguard Group, Inc. discloses a 5.53% interest in Dowlais Group plc through Form 8.3 filing under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Takeover Code Interests Disclosure Dowlais Group Plc
PRESS RELEASE published on 01/26/2026 at 16:01, 9 months 13 days ago Form 8.3 - The Vanguard Group, Inc.: Auction Technology Group plc The Vanguard Group, Inc. discloses a 3.55% stake in Auction Technology Group plc with 4,297,980 shares. Purchase of 1,020 shares at 3.31 GBP each Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Auction Technology Group PLC
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 20 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 20 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 09:00, 13 minutes ago Cantourage further develops Telecan and strengthens digital access to medical care
Published on 11/09/2026 at 09:00, 14 minutes ago Municipality Finance issues a GBP 50 million tap under its MTN programme
Published on 11/09/2026 at 09:00, 14 minutes ago Municipality Finance issues EUR 47.5 million zero coupon notes under its MTN programme
Published on 11/09/2026 at 09:00, 14 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 11/09/2026 at 07:00, 2 hours 14 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 2 hours 14 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/06/2026 at 17:54, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
